|
Name |
Thiocladospolide J
|
Molecular Formula | C27H42O10S | |
IUPAC Name* |
[(2R,8S)-8-hydroxy-8-[(2S)-5-oxo-2H-furan-2-yl]octan-2-yl] (2S)-2-hydroxy-3-[[(3S,6S,12R)-6-hydroxy-12-methyl-2,5-dioxo-oxacyclododec-3-yl]sulfanyl]propanoate
|
|
SMILES |
C[C@@H]1CCCCC[C@@H](C(=O)C[C@@H](C(=O)O1)SC[C@H](C(=O)O[C@H](C)CCCCC[C@@H]([C@@H]2C=CC(=O)O2)O)O)O
|
|
InChI |
InChI=1S/C27H42O10S/c1-17(9-6-4-8-12-20(29)23-13-14-25(32)37-23)35-26(33)22(31)16-38-24-15-21(30)19(28)11-7-3-5-10-18(2)36-27(24)34/h13-14,17-20,22-24,28-29,31H,3-12,15-16H2,1-2H3/t17-,18-,19+,20+,22-,23+,24+/m1/s1
|
|
InChIKey |
KPILJRSNGLXCKI-VJDUZYELSA-N
|
|
Synonyms |
Thiocladospolide J
|
|
CAS | NA | |
PubChem CID | 156582699 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 558.7 | ALogp: | 3.2 |
HBD: | 3 | HBA: | 11 |
Rotatable Bonds: | 13 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 182.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 38 | QED Weighted: | 0.184 |
Caco-2 Permeability: | -5.386 | MDCK Permeability: | 0.00000889 |
Pgp-inhibitor: | 0.317 | Pgp-substrate: | 0.995 |
Human Intestinal Absorption (HIA): | 0.079 | 20% Bioavailability (F20%): | 0.961 |
30% Bioavailability (F30%): | 0.918 |
Blood-Brain-Barrier Penetration (BBB): | 0.109 | Plasma Protein Binding (PPB): | 93.36% |
Volume Distribution (VD): | 1.045 | Fu: | 4.84% |
CYP1A2-inhibitor: | 0.029 | CYP1A2-substrate: | 0.198 |
CYP2C19-inhibitor: | 0.042 | CYP2C19-substrate: | 0.107 |
CYP2C9-inhibitor: | 0.501 | CYP2C9-substrate: | 0.984 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.129 |
CYP3A4-inhibitor: | 0.102 | CYP3A4-substrate: | 0.095 |
Clearance (CL): | 6.05 | Half-life (T1/2): | 0.927 |
hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.418 |
Drug-inuced Liver Injury (DILI): | 0.775 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.888 | Maximum Recommended Daily Dose: | 0.953 |
Skin Sensitization: | 0.182 | Carcinogencity: | 0.847 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.018 |
Respiratory Toxicity: | 0.125 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004421 | 0.699 | D0X8KY | 0.244 | ||||
ENC004419 | 0.532 | D01WUA | 0.235 | ||||
ENC002048 | 0.453 | D02RQU | 0.232 | ||||
ENC003570 | 0.424 | D0K7HU | 0.230 | ||||
ENC004420 | 0.398 | D0ZI4H | 0.219 | ||||
ENC002163 | 0.380 | D0N3NO | 0.218 | ||||
ENC004418 | 0.371 | D06WTZ | 0.217 | ||||
ENC002063 | 0.361 | D0I4DQ | 0.217 | ||||
ENC004295 | 0.336 | D0V0IX | 0.215 | ||||
ENC004121 | 0.333 | D0M5OC | 0.215 |